2nd ESO-ESSO Masterclass in Colorectal Cancer Surgery

Chairs: T. Wiggers, NL - L. Påhlman, SE - K. Havenga, NL


AIMS AND OBJECTIVES
Based on the knowledge of total mesocolon and total mesorectal surgey and imaging before the operation, after the Masterclass participants will be able to answer the 10 following questions:

• Is screening to be implemented?
• How does staging influence clinical decision making?
• Which information may influence treatment choices?
• Where do I damage the autonomic nerve plexus?
• How and when can I minimize the procedure?
• How do I position the patient for the perineal phase and perform a wide excision for low rectal cancers?
• How do I deal with the loss of a pelvic floor after a wide perineal resection and how do I correct a perineal hernia?
• How do I estimate the ned of a defunctioning colostomy and how do treat leakage of the anastomosis?
• How do treat a patient with colorectal cancer and synchronous liver metastases?
• How do I balance the advantages and disadvantages of adjuvant treatment (numbers needed to treat)?


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages.
Workshop Sessions in small groups will be organised in areas of decision making in complex cases.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and faculty.
All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.


THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts will contribute to the programme

FOR FURTHER INFORMATION PLEASE CONTACT:
Carine Lecoq
Society Co-ordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83 - B-1200 Brussels
Tel: +32 2 537 31 06
Fax: +32 2 539 03 74
e-mail: info@essoweb.org
url: www.essoweb.org


PARTICIPATION
Attendance is limited to 40 participants and admittance is by competitive application only. The successful of applicants are granted free registration but a contribution to the costs of full-board accommodation at the course venue (EUR 600 for ESSO/ESO club members and EUR 700 for non-members) travel and one free dinner are to be covered by the participants.


ACCREDITATION
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Following accreditation approval by ACOE  this event has been granted European endorsement by the UEMS and awarded 27 European Continuing Medical Education Credits (ECMEC).
  

FACULTY (as of November)
G. Baatrup, Haukeland University Hospital, Department of Surgery, Section of Colorectal Surgery, Bergen, NO
H. Becker, Geog-August-University, Department of General Surgery, Göttingen, DE
G. Beets, Academic Hospital Maastricht, Department of Surgery, Maastricht, NL
M. de Ruiter, Leiden University Medical Center, Department of Anatomy and Embryology, Leiden, NL
I. Edhemovic, Institute of Oncology, Dept. of Surgery, Ljubljana, SI
O. Glehen, Centre Hospitalier Lyon Sud, Dept. of Surgical Oncology, Pierre Bénite, FR
K. Havenga, University Medical Centre Groningen, Department of Surgery, Groningen, NL
T. Holm, Karolinska University Hospital, Department of Surgery, Stockholm, SE
K. Homayounfar, Universitätsmedizin Göttingen, Georg-August-Universität, Klinik für Allgemein- und Viszeralchirurgie, Göttingen, DE
A. Lindblom, Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, SE
L. Påhlman, University Hospital Uppsala, Department of Surgical Sciences, Section of Surgery, Uppsala, SE
P. Pfeiffer, Odense University Hospital, Institute of Clinical Research, Dept. of Oncology, Odense, DK
G.J. Poston, Aintree University Hospital, Department of Surgery, Liverpool, UK
N. Scott, St. James’s University Hospital, Department of Histopathology, Leeds, UK
P. Tekkis, The Royal Marsden Hospital, Department of Surgery, St. Mary’s NHS Trust, London, UK
E. Tiret, Saint-Antoine Hospital, Centre for Digestive Surgery, Paris, FR
V. Valentini, Cattedra di Radioterapia - Istituto di Radiologia, Policlinico Gemelli Università Cattolica S. Cuore, Rome, IT
T. Wiggers, University Medical Centre Groningen, Department of Surgery, Groningen, NL

23 February

24 February

25 February

26 February

27 February

28 February